Teplizumab, Drug developed by UCSF researcher strikingly effective in type 1 diabetes clinical trial

Patients who benefited most were those who still had relatively good control of their blood sugar levels and only a moderate need for insulin injections when the trial began. With the experimental drug, teplizumab, they were able to maintain their level of insulin production for the full two years — longer than with most other drugs tested against the disease.

Read more

Posted in Drugs